Insiders / Marks Gilbert Lynn / Activity
Activity — Marks Gilbert Lynn
8 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 12, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Common Stock | $0 | +12K +18.13% | 75,309 0.20% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -24K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +24K | 23,742 0.06% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -10K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +10K | 10,362 0.03% of shares | low |
| Mar 19, 2026 | Other | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | -11K -100.00% | 0 0.00% of shares | low |
| Mar 19, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (right to buy) | — | +11K | 10,665 0.03% of shares | low |
| Feb 20, 2026 | Grant | ANTX AN2 Therapeutics, Inc. Stock Option (Right to Buy) | — | +20K | 20,400 0.05% of shares | low |